Trinity Biotech | TRIB - Sales Revenues


Trinity Biotech reported $14.31M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
EDAP TMS EUR 13.88M 2.16M Sep/2025
J&J USD 24.6B 610M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.31M 73K Dec/2023
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 19.14B 2.29B Dec/2025
Surmodics USD 29.92M 96.16M Dec/2024
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Tosoh JPY 256.94B 2.93B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025
Veracyte USD 140.6M 8.7M Dec/2025